Scotia Capital’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28M | Buy |
5,699
+11
| +0.2% | +$2.74K | 0.01% | 533 |
|
|
2025
Q4 | $1.37M | Sell |
5,688
-155
| -3% | -$39.6K | 0.01% | 519 |
|
|
2025
Q3 | $1.6M | Sell |
5,843
-2,342
| -29% | -$640K | 0.01% | 485 |
|
|
2025
Q2 | $2.11M | Sell |
8,185
-1,778
| -18% | -$424K | 0.01% | 414 |
|
|
2025
Q1 | $2.23M | Sell |
9,963
-601
| -6% | -$140K | 0.01% | 388 |
|
|
2024
Q4 | $2.42M | Buy |
10,564
+2,890
| +38% | +$696K | 0.01% | 378 |
|
|
2024
Q3 | $1.87M | Buy |
7,674
+278
| +4% | +$62.1K | 0.01% | 400 |
|
|
2024
Q2 | $1.42M | Buy |
7,396
+551
| +8% | +$112K | 0.01% | 436 |
|
|
2024
Q1 | $1.36M | Buy |
+6,845
| New | +$1.25M | 0.01% | 440 |
|
|
2023
Q3 | – | Sell |
-1,003
| Closed | -$219K | – | 815 |
|
|
2023
Q2 | $219K | Hold |
1,003
| – | – | ﹤0.01% | 716 |
|
|
2023
Q1 | $220K | Hold |
1,003
| – | – | ﹤0.01% | 698 |
|
|
2022
Q4 | $209K | Hold |
1,003
| – | – | ﹤0.01% | 707 |
|
|
2022
Q3 | $219K | Sell |
1,003
-1
| -0.1% | -$228 | ﹤0.01% | 691 |
|
|
2022
Q2 | $211K | Sell |
1,004
-2
| -0.2% | -$426 | ﹤0.01% | 723 |
|
|
2022
Q1 | $244K | Buy |
1,006
+1
| +0.1% | +$242 | ﹤0.01% | 774 |
|
|
2021
Q4 | $262K | Sell |
1,005
-7
| -0.7% | -$1.82K | ﹤0.01% | 764 |
|
|
2021
Q3 | $267K | Buy |
1,012
+7
| +0.7% | +$1.91K | ﹤0.01% | 752 |
|
|
2021
Q2 | $248K | Buy |
+1,005
| New | +$211K | ﹤0.01% | 742 |
|
|
2020
Q2 | – | Sell |
-2,063
| Closed | -$304K | – | 713 |
|
|
2020
Q1 | $304K | Buy |
+2,063
| New | +$329K | ﹤0.01% | 499 |
|
|
2018
Q4 | – | Sell |
-1,762
| Closed | -$203K | – | 718 |
|
|
2018
Q3 | $203K | Buy |
+1,762
| New | +$193K | ﹤0.01% | 670 |
|
|
2017
Q2 | – | Sell |
-15,651
| Closed | -$1.13M | – | 732 |
|
|
2017
Q1 | $1.13M | Sell |
15,651
-1,841
| -11% | -$127K | 0.02% | 358 |
|
|
2016
Q4 | $1.09M | Buy |
17,492
+6,852
| +64% | +$420K | 0.02% | 422 |
|
|
2016
Q3 | $687K | Buy |
10,640
+1,119
| +12% | +$74.5K | 0.01% | 496 |
|
|
2016
Q2 | $602K | Buy |
9,521
+703
| +8% | +$41.4K | 0.01% | 480 |
|
|
2016
Q1 | $510K | Buy |
+8,818
| New | +$499K | 0.01% | 468 |
|
|
2014
Q2 | – | Sell |
-12,145
| Closed | -$543K | – | 599 |
|
|
2014
Q1 | $543K | Buy |
+12,145
| New | +$546K | 0.01% | 389 |
|
Other funds holding RMD
VCM
VPM
DAM
Scotia Capital's RMD Position: Q1 2026 in Review
Scotia Capital increased its ResMed (RMD) stake by 0.19% in Q1 2026, buying an estimated $2.74K and bringing the position to 5,699 shares worth $1.28M. The position accounts for 0.01% of the portfolio, ranked #533.
Scotia Capital first reported a position in RMD in Q1 2014 and has held it in 26 quarters since. The position peaked at $2.42M in Q4 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.
- Scotia Capital held 5,699 shares of ResMed worth $1.28M as of Q1 2026.
- Scotia Capital bought 11 ResMed shares in Q1 2026, an estimated $2.74K.
- ResMed made up 0.01% of Scotia Capital's portfolio in Q1 2026, its #533 holding.
- Scotia Capital first reported a position in ResMed in Q1 2014 and has held it in 26 quarters since.
- Scotia Capital's ResMed position peaked at $2.42M in Q4 2024.
- 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.